Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1995 Aug;69(8):5095–5102. doi: 10.1128/jvi.69.8.5095-5102.1995

Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.

D A Largaespada 1, J D Shaughnessy Jr 1, N A Jenkins 1, N G Copeland 1
PMCID: PMC189327  PMID: 7609078

Abstract

Approximately 15% of BXH-2 myeloid leukemias harbor proviral integrations at the Evi-2 common viral integration site. Evi-2 is located within a large intron of the Nf1 tumor suppressor gene, raising the possibility that proviral integration at Evi-2 predisposes mice to myeloid tumor development by disrupting Nf1 expression. This hypothesis is supported by data suggesting that mutations in the human NF1 gene are causally associated with the development of juvenile chronic myelogenous leukemia (K. M. Shannon, P. O'Connell, G. A. Martin, D. Paderanga, K. Olson, P. Dinndorf, and F. McCormick, N. Engl. J. Med. 330:597-601, 1994) and mouse studies showing that aged mice, heterozygous for a germ line Nf1 mutation, develop myeloid leukemia with loss of the wild-type Nf1 allele (T. Jacks, T. S. Shih, E. M. Schmitt, R. T. Bronson, A. Bernards, and R. A. Weinberg, Nat. Genet. 7:353-361, 1994). To determine if viral integration at Evi-2 disrupts Nf1 expression, we derived a series of BXH-2 myeloid leukemia cell lines with or without viral integrations at Evi-2. In all cell lines examined, viral integration at Evi-2 resulted in the production of only truncated Nf1 transcripts and no stable, full-length neurofibromin. Although neurofibromin is a GTPase-activating protein (GAP) for p21ras proteins, its loss in the BXH-2 leukemic cell lines was not correlated with an increased steady-state level of p21ras bound to GTP. These data suggest that neurofibromin is not the sole mediator of Ras-GAP activity in myeloid cells and may have a GAP-independent function in myeloid cells.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alt F., Rosenberg N., Lewis S., Thomas E., Baltimore D. Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell. 1981 Dec;27(2 Pt 1):381–390. doi: 10.1016/0092-8674(81)90421-9. [DOI] [PubMed] [Google Scholar]
  2. Bader J. L., Miller R. W. Neurofibromatosis and childhood leukemia. J Pediatr. 1978 Jun;92(6):925–929. doi: 10.1016/s0022-3476(78)80362-x. [DOI] [PubMed] [Google Scholar]
  3. Bader J. L. Neurofibromatosis and cancer. Ann N Y Acad Sci. 1986;486:57–65. doi: 10.1111/j.1749-6632.1986.tb48062.x. [DOI] [PubMed] [Google Scholar]
  4. Badley J. E., Bishop G. A., St John T., Frelinger J. A. A simple, rapid method for the purification of poly A+ RNA. Biotechniques. 1988 Feb;6(2):114–116. [PubMed] [Google Scholar]
  5. Basu T. N., Gutmann D. H., Fletcher J. A., Glover T. W., Collins F. S., Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature. 1992 Apr 23;356(6371):713–715. doi: 10.1038/356713a0. [DOI] [PubMed] [Google Scholar]
  6. Bedigian H. G., Johnson D. A., Jenkins N. A., Copeland N. G., Evans R. Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice. J Virol. 1984 Sep;51(3):586–594. doi: 10.1128/jvi.51.3.586-594.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bedigian H. G., Taylor B. A., Meier H. Expression of murine leukemia viruses in the highly lymphomatous BXH-2 recombinant inbred mouse strain. J Virol. 1981 Aug;39(2):632–640. doi: 10.1128/jvi.39.2.632-640.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ben David Y., Prideaux V. R., Chow V., Benchimol S., Bernstein A. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Oncogene. 1988 Aug;3(2):179–185. [PubMed] [Google Scholar]
  9. Berman J. W., Basch R. S. Thy-1 antigen expression by murine hematopoietic precursor cells. Exp Hematol. 1985 Dec;13(11):1152–1156. [PubMed] [Google Scholar]
  10. Bourne H. R., Sanders D. A., McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature. 1990 Nov 8;348(6297):125–132. doi: 10.1038/348125a0. [DOI] [PubMed] [Google Scholar]
  11. Brannan C. I., Perkins A. S., Vogel K. S., Ratner N., Nordlund M. L., Reid S. W., Buchberg A. M., Jenkins N. A., Parada L. F., Copeland N. G. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 1994 May 1;8(9):1019–1029. doi: 10.1101/gad.8.9.1019. [DOI] [PubMed] [Google Scholar]
  12. Buchberg A. M., Bedigian H. G., Jenkins N. A., Copeland N. G. Evi-2, a common integration site involved in murine myeloid leukemogenesis. Mol Cell Biol. 1990 Sep;10(9):4658–4666. doi: 10.1128/mcb.10.9.4658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Buchberg A. M., Cleveland L. S., Jenkins N. A., Copeland N. G. Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway. Nature. 1990 Sep 20;347(6290):291–294. doi: 10.1038/347291a0. [DOI] [PubMed] [Google Scholar]
  14. Cawthon R. M., Andersen L. B., Buchberg A. M., Xu G. F., O'Connell P., Viskochil D., Weiss R. B., Wallace M. R., Marchuk D. A., Culver M. cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene. Genomics. 1991 Mar;9(3):446–460. doi: 10.1016/0888-7543(91)90410-g. [DOI] [PubMed] [Google Scholar]
  15. Chattopadhyay S. K., Lander M. R., Rands E., Lowy D. R. Structure of endogenous murine leukemia virus DNA in mouse genomes. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5774–5778. doi: 10.1073/pnas.77.10.5774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Church G. M., Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984 Apr;81(7):1991–1995. doi: 10.1073/pnas.81.7.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Daston M. M., Scrable H., Nordlund M., Sturbaum A. K., Nissen L. M., Ratner N. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron. 1992 Mar;8(3):415–428. doi: 10.1016/0896-6273(92)90270-n. [DOI] [PubMed] [Google Scholar]
  18. DeClue J. E., Papageorge A. G., Fletcher J. A., Diehl S. R., Ratner N., Vass W. C., Lowy D. R. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell. 1992 Apr 17;69(2):265–273. doi: 10.1016/0092-8674(92)90407-4. [DOI] [PubMed] [Google Scholar]
  19. Fort P., Marty L., Piechaczyk M., el Sabrouty S., Dani C., Jeanteur P., Blanchard J. M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985 Mar 11;13(5):1431–1442. doi: 10.1093/nar/13.5.1431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Furth M. E., Davis L. J., Fleurdelys B., Scolnick E. M. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J Virol. 1982 Jul;43(1):294–304. doi: 10.1128/jvi.43.1.294-304.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ghione F., Mecucci C., Symann M., Michaux J. L., Casteels-Van Daele M., Van den Berghe H. Cytogenetic investigations in childhood chronic myelocytic leukemia. Cancer Genet Cytogenet. 1986 Feb 15;20(3-4):317–323. doi: 10.1016/0165-4608(86)90090-7. [DOI] [PubMed] [Google Scholar]
  22. Gutmann D. H., Collins F. S. The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron. 1993 Mar;10(3):335–343. doi: 10.1016/0896-6273(93)90324-k. [DOI] [PubMed] [Google Scholar]
  23. Hicks G. G., Mowat M. Integration of Friend murine leukemia virus into both alleles of the p53 oncogene in an erythroleukemic cell line. J Virol. 1988 Dec;62(12):4752–4755. doi: 10.1128/jvi.62.12.4752-4755.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Holmes K. L., Morse H. C., 3rd Murine hematopoietic cell surface antigen expression. Immunol Today. 1988 Nov;9(11):344–350. doi: 10.1016/0167-5699(88)91335-7. [DOI] [PubMed] [Google Scholar]
  25. Huynh D. P., Nechiporuk T., Pulst S. M. Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Dev Biol. 1994 Feb;161(2):538–551. doi: 10.1006/dbio.1994.1052. [DOI] [PubMed] [Google Scholar]
  26. Jacks T., Shih T. S., Schmitt E. M., Bronson R. T., Bernards A., Weinberg R. A. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet. 1994 Jul;7(3):353–361. doi: 10.1038/ng0794-353. [DOI] [PubMed] [Google Scholar]
  27. Jenkins N. A., Copeland N. G., Taylor B. A., Bedigian H. G., Lee B. K. Ecotropic murine leukemia virus DNA content of normal and lymphomatous tissues of BXH-2 recombinant inbred mice. J Virol. 1982 May;42(2):379–388. doi: 10.1128/jvi.42.2.379-388.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Johnson M. R., DeClue J. E., Felzmann S., Vass W. C., Xu G., White R., Lowy D. R. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol. 1994 Jan;14(1):641–645. doi: 10.1128/mcb.14.1.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Johnson M. R., Look A. T., DeClue J. E., Valentine M. B., Lowy D. R. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5539–5543. doi: 10.1073/pnas.90.12.5539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kalra R., Paderanga D. C., Olson K., Shannon K. M. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Blood. 1994 Nov 15;84(10):3435–3439. [PubMed] [Google Scholar]
  31. Krause D. S., Ito T., Fackler M. J., Smith O. M., Collector M. I., Sharkis S. J., May W. S. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood. 1994 Aug 1;84(3):691–701. [PubMed] [Google Scholar]
  32. Kronenberg M., Goverman J., Haars R., Malissen M., Kraig E., Phillips L., Delovitch T., Suciu-Foca N., Hood L. Rearrangement and transcription of the beta-chain genes of the T-cell antigen receptor in different types of murine lymphocytes. Nature. 1985 Feb 21;313(6004):647–653. doi: 10.1038/313647a0. [DOI] [PubMed] [Google Scholar]
  33. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  34. Lanier L. L., Warner N. L. Cell cycle related heterogeneity of Ia antigen expression on a murine B lymphoma cell line:analysis by flow cytometry. J Immunol. 1981 Feb;126(2):626–631. [PubMed] [Google Scholar]
  35. Lübbert M., Herrmann F., Koeffler H. P. Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells. Blood. 1991 Mar 1;77(5):909–924. [PubMed] [Google Scholar]
  36. Lübbert M., Mirro J., Jr, Kitchingman G., McCormick F., Mertelsmann R., Herrmann F., Koeffler H. P. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Oncogene. 1992 Feb;7(2):263–268. [PubMed] [Google Scholar]
  37. Mardon G., Page D. C. The sex-determining region of the mouse Y chromosome encodes a protein with a highly acidic domain and 13 zinc fingers. Cell. 1989 Mar 10;56(5):765–770. doi: 10.1016/0092-8674(89)90680-6. [DOI] [PubMed] [Google Scholar]
  38. Martin G. A., Viskochil D., Bollag G., McCabe P. C., Crosier W. J., Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R. M. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell. 1990 Nov 16;63(4):843–849. doi: 10.1016/0092-8674(90)90150-d. [DOI] [PubMed] [Google Scholar]
  39. Max E. E., Seidman J. G., Leder P. Sequences of five potential recombination sites encoded close to an immunoglobulin kappa constant region gene. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3450–3454. doi: 10.1073/pnas.76.7.3450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Mikol D. D., Gulcher J. R., Stefansson K. The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J Cell Biol. 1990 Feb;110(2):471–479. doi: 10.1083/jcb.110.2.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Miller B. A., Lipton J. M., Linch D. C., Burakoff S. J., Nathan D. G. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors. J Cell Physiol. 1985 Apr;123(1):25–32. doi: 10.1002/jcp.1041230105. [DOI] [PubMed] [Google Scholar]
  42. Mucenski M. L., Taylor B. A., Jenkins N. A., Copeland N. G. AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas. Mol Cell Biol. 1986 Dec;6(12):4236–4243. doi: 10.1128/mcb.6.12.4236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Neubauer A., Shannon K., Liu E. Mutations of the ras proto-oncogenes in childhood monosomy 7. Blood. 1991 Feb 1;77(3):594–598. [PubMed] [Google Scholar]
  44. Old L. J., Boyse E. A., Stockert E. The G (Gross) leukemia antigen. Cancer Res. 1965 Jul;25(6):813–819. [PubMed] [Google Scholar]
  45. Paige C. J., Kincade P. W., Ralph P. Murine B cell leukemia line with inducible surface immunoglobulin expression. J Immunol. 1978 Aug;121(2):641–647. [PubMed] [Google Scholar]
  46. Puil L., Liu J., Gish G., Mbamalu G., Bowtell D., Pelicci P. G., Arlinghaus R., Pawson T. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 1994 Feb 15;13(4):764–773. doi: 10.1002/j.1460-2075.1994.tb06319.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Ralph P., Nakoinz I. Direct toxic effects of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture. Cancer Res. 1977 Feb;37(2):546–550. [PubMed] [Google Scholar]
  48. Rey I., Taylor-Harris P., van Erp H., Hall A. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation. Oncogene. 1994 Mar;9(3):685–692. [PubMed] [Google Scholar]
  49. Ru M., Shustik C., Rassart E. Graffi murine leukemia virus: molecular cloning and characterization of the myeloid leukemia-inducing agent. J Virol. 1993 Aug;67(8):4722–4731. doi: 10.1128/jvi.67.8.4722-4731.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Sawyers C. L., Denny C. T. Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about. Cell. 1994 Apr 22;77(2):171–173. doi: 10.1016/0092-8674(94)90307-7. [DOI] [PubMed] [Google Scholar]
  51. Scherdin U., Rhodes K., Breindl M. Transcriptionally active genome regions are preferred targets for retrovirus integration. J Virol. 1990 Feb;64(2):907–912. doi: 10.1128/jvi.64.2.907-912.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Shannon K. M., O'Connell P., Martin G. A., Paderanga D., Olson K., Dinndorf P., McCormick F. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med. 1994 Mar 3;330(9):597–601. doi: 10.1056/NEJM199403033300903. [DOI] [PubMed] [Google Scholar]
  53. Spangrude G. J., Heimfeld S., Weissman I. L. Purification and characterization of mouse hematopoietic stem cells. Science. 1988 Jul 1;241(4861):58–62. doi: 10.1126/science.2898810. [DOI] [PubMed] [Google Scholar]
  54. Sutherland D. R., Keating A. The CD34 antigen: structure, biology, and potential clinical applications. J Hematother. 1992 Summer;1(2):115–129. doi: 10.1089/scd.1.1992.1.115. [DOI] [PubMed] [Google Scholar]
  55. The I., Murthy A. E., Hannigan G. E., Jacoby L. B., Menon A. G., Gusella J. F., Bernards A. Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat Genet. 1993 Jan;3(1):62–66. doi: 10.1038/ng0193-62. [DOI] [PubMed] [Google Scholar]
  56. Tsao S. G., Brunk C. F., Pearlman R. E. Hybridization of nucleic acids directly in agarose gels. Anal Biochem. 1983 Jun;131(2):365–372. doi: 10.1016/0003-2697(83)90185-9. [DOI] [PubMed] [Google Scholar]
  57. Viskochil D., Buchberg A. M., Xu G., Cawthon R. M., Stevens J., Wolff R. K., Culver M., Carey J. C., Copeland N. G., Jenkins N. A. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990 Jul 13;62(1):187–192. doi: 10.1016/0092-8674(90)90252-a. [DOI] [PubMed] [Google Scholar]
  58. Viskochil D., Cawthon R., O'Connell P., Xu G. F., Stevens J., Culver M., Carey J., White R. The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene. Mol Cell Biol. 1991 Feb;11(2):906–912. doi: 10.1128/mcb.11.2.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Wallace M. R., Marchuk D. A., Andersen L. B., Letcher R., Odeh H. M., Saulino A. M., Fountain J. W., Brereton A., Nicholson J., Mitchell A. L. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990 Jul 13;249(4965):181–186. doi: 10.1126/science.2134734. [DOI] [PubMed] [Google Scholar]
  60. Warne P. H., Viciana P. R., Downward J. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature. 1993 Jul 22;364(6435):352–355. doi: 10.1038/364352a0. [DOI] [PubMed] [Google Scholar]
  61. Xu G. F., O'Connell P., Viskochil D., Cawthon R., Robertson M., Culver M., Dunn D., Stevens J., Gesteland R., White R. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990 Aug 10;62(3):599–608. doi: 10.1016/0092-8674(90)90024-9. [DOI] [PubMed] [Google Scholar]
  62. Zhang K., Papageorge A. G., Lowy D. R. Mechanistic aspects of signaling through Ras in NIH 3T3 cells. Science. 1992 Jul 31;257(5070):671–674. doi: 10.1126/science.1496380. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES